Birdwatch Note
2024-12-28 00:16:50 UTC - MISINFORMED_OR_POTENTIALLY_MISLEADING
下記の資料の42p等にこのモデルナと国防省の契約の文言は見れますが、41pに下記のように記載があり、コロナワクチンを軍用に使うというのは、拡散している引用文言とは違い、米軍兵士が直面する疾患の予防のためにこれを使えるという意味にすぎません。 国防総省の医療製品の優先順位。PL 115-92 により、DoD は、米軍兵士が直面する重篤な、または生命を脅かす疾患や状態の診断、治療、予防のための製品開発を促進するための支援を要請し、FDA はこれを提供することができる。 https://www.hhs.gov/sites/default/files/moderna-covid-19-vaccine-contract.pdf#page=41
Written by 41A6243EF0C5E2F69F5A0D4006A468F4F7CBEC237CAE6ACCC5FB56ED687492FE
Participant Details
Original Tweet
Tweet embedding is no longer reliably available, due to the platform's instability (in terms of both technology and policy). If the Tweet still exists, you can view it here: https://twitter.com/foo_bar/status/1872703471461515559
Please note, though, that you may need to have your own Twitter account to access that page. I am currently exploring options for archiving Tweet data in a post-API context.
All Information
- ID - 1872798828652577015
- noteId - 1872798828652577015
- participantId -
- noteAuthorParticipantId - 41A6243EF0C5E2F69F5A0D4006A468F4F7CBEC237CAE6ACCC5FB56ED687492FE Participant Details
- createdAtMillis - 1735345010328
- tweetId - 1872703471461515559
- classification - MISINFORMED_OR_POTENTIALLY_MISLEADING
- believable -
- harmful -
- validationDifficulty -
- misleadingOther - 0
- misleadingFactualError - 1
- misleadingManipulatedMedia - 1
- misleadingOutdatedInformation - 0
- misleadingMissingImportantContext - 0
- misleadingUnverifiedClaimAsFact - 1
- misleadingSatire - 1
- notMisleadingOther - 0
- notMisleadingFactuallyCorrect - 0
- notMisleadingOutdatedButNotWhenWritten - 0
- notMisleadingClearlySatire - 0
- notMisleadingPersonalOpinion - 0
- trustworthySources - 1
- summary
- 下記の資料の42p等にこのモデルナと国防省の契約の文言は見れますが、41pに下記のように記載があり、コロナワクチンを軍用に使うというのは、拡散している引用文言とは違い、米軍兵士が直面する疾患の予防のためにこれを使えるという意味にすぎません。 国防総省の医療製品の優先順位。PL 115-92 により、DoD は、米軍兵士が直面する重篤な、または生命を脅かす疾患や状態の診断、治療、予防のための製品開発を促進するための支援を要請し、FDA はこれを提供することができる。 https://www.hhs.gov/sites/default/files/moderna-covid-19-vaccine-contract.pdf#page=41
Note Ratings
| rated at | rated by | |
| 2025-01-02 05:42:44 -0600 | Rating Details | |
| 2024-12-28 16:11:02 -0600 | Rating Details | |
| 2024-12-28 04:15:53 -0600 | Rating Details | |
| 2024-12-28 03:49:44 -0600 | Rating Details | |
| 2024-12-28 02:54:53 -0600 | Rating Details | |
| 2024-12-28 00:45:24 -0600 | Rating Details | |
| 2024-12-28 00:37:20 -0600 | Rating Details | |
| 2024-12-27 22:40:23 -0600 | Rating Details | |
| 2024-12-27 22:07:02 -0600 | Rating Details | |
| 2024-12-27 21:56:36 -0600 | Rating Details | |
| 2024-12-27 21:54:27 -0600 | Rating Details | |
| 2024-12-27 21:34:35 -0600 | Rating Details | |
| 2024-12-27 21:23:22 -0600 | Rating Details | |
| 2024-12-27 20:43:35 -0600 | Rating Details | |
| 2024-12-27 18:19:14 -0600 | Rating Details | |
| 2025-01-02 07:10:24 -0600 | Rating Details | |
| 2024-12-31 22:27:53 -0600 | Rating Details | |
| 2024-12-28 17:57:29 -0600 | Rating Details | |
| 2024-12-28 16:42:39 -0600 | Rating Details | |
| 2024-12-28 09:27:18 -0600 | Rating Details | |
| 2024-12-28 09:02:18 -0600 | Rating Details | |
| 2024-12-28 06:28:57 -0600 | Rating Details | |
| 2024-12-28 06:25:52 -0600 | Rating Details | |
| 2024-12-28 06:04:11 -0600 | Rating Details | |
| 2024-12-28 01:10:20 -0600 | Rating Details | |
| 2024-12-28 00:29:13 -0600 | Rating Details | |
| 2024-12-27 23:11:53 -0600 | Rating Details | |
| 2024-12-27 23:05:32 -0600 | Rating Details | |
| 2024-12-27 22:12:58 -0600 | Rating Details | |
| 2024-12-27 22:00:29 -0600 | Rating Details | |
| 2024-12-27 21:37:12 -0600 | Rating Details | |
| 2024-12-27 21:20:41 -0600 | Rating Details | |
| 2024-12-27 20:36:03 -0600 | Rating Details | |
| 2024-12-27 20:17:42 -0600 | Rating Details | |
| 2024-12-27 19:52:49 -0600 | Rating Details | |
| 2024-12-27 19:50:15 -0600 | Rating Details | |
| 2024-12-27 19:26:01 -0600 | Rating Details | |
| 2024-12-27 18:35:33 -0600 | Rating Details | |
| 2024-12-27 18:21:25 -0600 | Rating Details | |
| 2024-12-30 18:48:01 -0600 | Rating Details | |
| 2024-12-29 07:29:19 -0600 | Rating Details | |
| 2024-12-29 02:12:00 -0600 | Rating Details | |
| 2024-12-29 00:11:16 -0600 | Rating Details | |
| 2024-12-28 06:45:54 -0600 | Rating Details | |
| 2024-12-28 02:24:09 -0600 | Rating Details | |
| 2024-12-28 01:56:00 -0600 | Rating Details | |
| 2024-12-28 01:01:45 -0600 | Rating Details | |
| 2024-12-28 01:00:51 -0600 | Rating Details | |
| 2024-12-27 22:36:16 -0600 | Rating Details | |
| 2024-12-27 22:28:50 -0600 | Rating Details | |
| 2024-12-27 21:54:20 -0600 | Rating Details | |
| 2024-12-27 20:24:00 -0600 | Rating Details | |
| 2024-12-27 20:23:42 -0600 | Rating Details | |
| 2024-12-27 20:16:32 -0600 | Rating Details | |
| 2024-12-27 20:04:28 -0600 | Rating Details | |
| 2024-12-27 19:35:46 -0600 | Rating Details | |
| 2024-12-27 19:28:56 -0600 | Rating Details | |
| 2024-12-27 19:23:55 -0600 | Rating Details | |
| 2024-12-29 01:41:30 -0600 | Rating Details | |
| 2024-12-28 16:43:15 -0600 | Rating Details | |
| 2024-12-28 14:03:36 -0600 | Rating Details | |
| 2024-12-28 13:03:52 -0600 | Rating Details | |
| 2024-12-28 09:57:29 -0600 | Rating Details | |
| 2024-12-28 08:36:27 -0600 | Rating Details | |
| 2024-12-28 06:15:27 -0600 | Rating Details | |
| 2024-12-28 04:32:43 -0600 | Rating Details | |
| 2024-12-28 04:30:48 -0600 | Rating Details | |
| 2024-12-28 04:27:00 -0600 | Rating Details | |
| 2024-12-28 03:40:47 -0600 | Rating Details | |
| 2024-12-28 03:32:49 -0600 | Rating Details | |
| 2024-12-28 00:01:55 -0600 | Rating Details | |
| 2024-12-27 22:30:43 -0600 | Rating Details | |
| 2024-12-27 20:47:38 -0600 | Rating Details | |
| 2024-12-27 19:33:12 -0600 | Rating Details | |
| 2024-12-27 19:25:16 -0600 | Rating Details | |
| 2024-12-27 18:37:22 -0600 | Rating Details | |
| 2024-12-27 18:20:43 -0600 | Rating Details |